Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI-Powered MRI could slash heart scan time

NCT ID NCT07061821

Diagnosis Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new, faster cardiac MRI that uses artificial intelligence can accurately measure heart function in people with left ventricular hypertrophy (thickened heart muscle). The standard MRI requires multiple breath-holds, which can be hard for elderly or breathless patients. The new method aims to shorten scan time while maintaining image quality. Researchers will compare the two methods in 61 adults referred for a heart MRI.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
accelerated cardiac cine-MRI sequence with deep learning-based image reconstruction
What this could lead to
If successful, this could make heart MRI scans faster and more comfortable for patients, while still providing accurate measurements of heart function.
What could go wrong
This is a small, early-stage study (61 participants) comparing two imaging methods, not testing a treatment. The new method may not match the standard's accuracy in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 61 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient referred for cardiac MRI as part of the assessment or follow-up of left ventricular hypertrophy * Age ≥ 18 years old * Ability of the subject to understand and express his consent * Affiliation to the social security scheme Exclusion Criteria: * Severe obesity (\>140 kg) preventing the patient from entering the scanner bore, which has a diameter of less than 70 cm * Age ≥ 18 years old * Person under guardianship or curators, or deprived of liberty * Pregnant or breastfeeding woman * Known allergy to gadolinium chelates * Claustrophobia * Any contraindication to MRI * Arrhythmia * Inability to hold breath for more than 10 seconds

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac magnetic resonance imaging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hypertrophy, Left Ventricular

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac magnetic resonance imaging Deep learning Image reconstruction Left ventricular ejection fraction Left ventricular hypertrophy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Amiens

    RECRUITING

    Amiens, 80480, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.